APA (7th ed.) Citation

Chan, A., Buyse, M., & Yao, B. (2016). Neratinib after trastuzumab in patients with HER2-positive breast cancer - Author's reply. The Lancet Publishing Group.

Chicago Style (17th ed.) Citation

Chan, Arlene, M. Buyse, and B. Yao. Neratinib After Trastuzumab in Patients with HER2-positive Breast Cancer - Author's Reply. The Lancet Publishing Group, 2016.

MLA (9th ed.) Citation

Chan, Arlene, et al. Neratinib After Trastuzumab in Patients with HER2-positive Breast Cancer - Author's Reply. The Lancet Publishing Group, 2016.